ConductScience.org, home

Paper38726429

Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.

Rauf A and 9 others. Food Sci Nutr, 2024. Cited by 6 papers, by iCite. Retracted.

Cite this record

ConductScience Library. Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study. Papers, record 38726429. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38726429

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.
PubMed
Journal
Food Sci Nutr
PubMed
Year
2024
PubMed
Publication types
Journal Article, Retracted Publication
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.52, provisional
iCite
Retracted
Yes, by PubMed's record
PubMed
Revised in PubMed
2026-09-23
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rauf AAbdur
2Ibrahim MMuhammad
3Alomar TSTaghrid S
4AlMasoud NNajla
5Khalil AAAnees Ahmedhttps://orcid.org/0000-0003-3662-0933
6Khan MMuneeb
7Khalid AAhood
8Jan MSMuhammad Saeed
9Formanowicz DDorota
10Quradha MMMohammed Mansourhttps://orcid.org/0000-0002-8452-5343

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Retracted by42775171RETRACTION: Hypoglycemic, Anti-Inflammatory, and Neuroprotective Potentials of Crude Methanolic Extract From Acacia Nilotica L. - Results of an In Vitro Study.https://conductscience.org/library/papers/42775171

Source PubMed

Download CSV of comments and corrections

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129599720Ethnopharmacology-A Bibliometric Analysis of a Field of Research Meandering Between Medicine and Food Science?Front Pharmacol2018https://conductscience.org/library/papers/29599720PubMed
229467962Inflammatory responses and inflammation-associated diseases in organs.Oncotarget2018https://conductscience.org/library/papers/29467962PubMed
324350051In-vitro α amylase and glycosidase inhibitory effect of ethanolic extract of antiasthmatic drug - Shirishadi.J Adv Pharm Technol Res2013https://conductscience.org/library/papers/24350051PubMed
433335883Treating Hyperglycemia From Eryngium caeruleum M. Bieb: In-vitro α-Glucosidase, Antioxidant, in-vivo Antidiabetic and Molecular Docking-Based Approaches.Front Chem2020https://conductscience.org/library/papers/33335883PubMed
532226726Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action.Curr Pharmacol Rep2019https://conductscience.org/library/papers/32226726PubMed
630122972Medicinal plants with anti-inflammatory activities from selected countries and regions of Africa.J Inflamm Res2018https://conductscience.org/library/papers/30122972PubMed
720042775Diagnosis and classification of diabetes mellitus.Diabetes Care2010https://conductscience.org/library/papers/20042775PubMed
830477749Pharmacoepidemiology of non-steroidal anti-inflammatory drugs.Therapie2019https://conductscience.org/library/papers/30477749PubMed
924872833Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources.Evid Based Complement Alternat Med2014https://conductscience.org/library/papers/24872833PubMed
1032941929Alzheimer's disease: Recent treatment strategies.Eur J Pharmacol2020https://conductscience.org/library/papers/32941929PubMed
1123943383Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.Mol Nutr Food Res2014https://conductscience.org/library/papers/23943383PubMed
1233865830Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach.Eur J Pharmacol2021https://conductscience.org/library/papers/33865830PubMed
1333207605Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33207605PubMed
1431740050Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents.Eur J Med Chem2020https://conductscience.org/library/papers/31740050PubMed
1528611658Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants.Front Aging Neurosci2017https://conductscience.org/library/papers/28611658PubMed
1618424136Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides.Bioorg Med Chem Lett2008https://conductscience.org/library/papers/18424136PubMed
1711966455New trends in dual 5-LOX/COX inhibition.Curr Med Chem2002https://conductscience.org/library/papers/11966455PubMed
1829551098Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.Prim Health Care Res Dev2018https://conductscience.org/library/papers/29551098PubMed
1923090376Selective inhibition of cyclooxygenase-2: risks and benefits.Rev Bras Reumatol2012https://conductscience.org/library/papers/23090376PubMed
2023641947
Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes.
BMC Complement Altern Med2013https://conductscience.org/library/papers/23641947PubMed

See all 44 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42445685Exploring the Therapeutic Potential of Oenothera laciniata: Antioxidant, Anti-Hyperglycemic and Histopathological Activities Using In Vitro and In Vivo Approaches.Food Sci Nutr2026https://conductscience.org/library/papers/42445685PubMed
40389681A pharmaco-metabolomics study of Glycyrrhiza glabra, Boswellia sarca, and Acacia nilotica in acute allergic dermatitis.Inflammopharmacology2025https://conductscience.org/library/papers/40389681PubMed
39148976Pharmacological evaluation and binding behavior of 4,4'-diamino-2,2'-stilbene disulfonic acid with metal ions using spectroscopic techniques.Heliyon2024https://conductscience.org/library/papers/39148976PubMed
38726429Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.Food Sci Nutr2024https://conductscience.org/library/papers/38726429PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38726429

GET https://conductscience.org/api/papers/v1/38726429/references?page=2